Literature DB >> 1965075

Development of live, attenuated hepatitis A vaccine (H2-strain).

J S Mao1.   

Abstract

Hepatitis A, with high prevalence and high incidence, is one of the most serious infectious diseases in China. A programme aiming at developing a vaccine against hepatitis A has been in progress since 1980. The H2-strain vaccine that had been selected and studied in our laboratory was proven to be attenuated for human beings and has been proven to be effective in preventing hepatitis A. In the near future, the live, attenuated H2-strain vaccine derived from tissue culture will be available in China.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1965075     DOI： 10.1016/0264-410x(90)90001-3

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  8 in total

1.  Hepatitis A.

Authors:  A J Tilzey; J E Banatvala
Journal:  BMJ       Date:  1991-06-29

2.  H2 strain attenuated live hepatitis A vaccines:protective efficacy in a hepatitis A outbreak.

Authors:  Yu-Liang Zhao; Zong-Da Meng; Zhi-Yi Xu; Jun-Jie Guo; Shao-Ai Chai; Cheng-Gang Duo; Xuan-Yi Wang; Jin-Feng Yao; Hong-Bin Liu; Shun-Xiang Qi; Hui-Bin Zhu
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

Review 3.  Vaccination of adults against travel-related infectious diseases, and new developments in vaccines.

Authors:  P C Döller
Journal:  Infection       Date:  1993 Jan-Feb       Impact factor: 3.553

4.  Protective effect of inactivated hepatitis A vaccine against the outbreak of hepatitis A in an open rural community.

Authors:  Yue-Gen Shen; Xie-Jun Gu; Jian-Hong Zhou
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

5.  Clinical trial with inactivated hepatitis A vaccine and recommendations for its use.

Authors:  A J Tilzey; S J Palmer; S Barrow; K R Perry; H Tyrrell; A Safary; J E Banatvala
Journal:  BMJ       Date:  1992-05-16

6.  Era of vaccination heralds a decline in incidence of hepatitis A in high-risk groups in China.

Authors:  Zhuang Fangcheng; Wang Xuanyi; Chen Mingding; Jiang Liming; Wu Jie; Jiang Qi; Gong Yuanping; Qian Wen; Xin Yajuan; Mao Jiangsen
Journal:  Hepat Mon       Date:  2012-02-29       Impact factor: 0.660

7.  Long term follow-up study to evaluate immunogenicity and safety of a single dose of live attenuated hepatitis a vaccine in children.

Authors:  Monjori Mitra; Nitin Shah; Mma Faridi; Apurba Ghosh; V S Sankaranarayanan; Anju Aggarwal; Suparna Chatterjee; Nisha Bhattacharyya; Ganesh Kadhe; Gaurav Vishnoi; Amey Mane
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 8.  A review of immunogenicity and tolerability of live attenuated Hepatitis A vaccine in children.

Authors:  Sameer Rao; J S Mao; Salman Motlekar; Zhuang Fangcheng; Ganesh Kadhe
Journal:  Hum Vaccin Immunother       Date:  2016-12       Impact factor: 3.452
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.